iNOS and nNOS promote melanoma cell proliferation [112,113]; nNOS has a role in melanoma invasion [112]; iNOS is associated with increased resistance to cisplatin [114] and poor patient survival [115]; and eNOS is involved in lymphangiogenesis and lymphatic metastasis [116]. Here, NOS1 is linked to melanoma.